Champions Oncology Stock Forecast

Buy or Hold candidate since Dec 05, 2024 Gain 6.22%

The Champions Oncology stock price gained 6.22% on the last trading day (Friday, 6th Dec 2024), rising from $4.34 to $4.61. During the last trading day the stock fluctuated 6.96% from a day low at $4.31 to a day high of $4.61. The price has risen in 6 of the last 10 days and is up by 3.83% over the past 2 weeks. Volume fell on the last day by -13 thousand shares and in total, 3 thousand shares were bought and sold for approximately $16.06 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $4.77 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -5.90% during the next 3 months and, with a 90% probability hold a price between $3.45 and $4.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

CSBR Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, November 12, 2024, and so far it has fallen -0.647%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The Champions Oncology stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.39 and $4.31. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Champions Oncology stock

Champions Oncology finds support from accumulated volume at $4.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.300 between high and low, or 6.96%. For the last week the stock has had daily average volatility of 10.01%.

Our recommended stop-loss: $4.45 (-3.48%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (CSBR) For The Upcoming Trading Day Of Monday 9th

For the upcoming trading day on Monday, 9th we expect Champions Oncology to open at $4.51, and during the day (based on 14 day Average True Range), to move between $4.29 and $4.93, which gives a possible trading interval of +/-$0.321 (+/-6.96%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 13.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.60 (0.22%) than the resistance at $4.89 (6.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Champions Oncology stock A Buy?

Champions Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.324 Hold/Accumulate Downgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on December 9, 2024 - $4.51 ( 2.17%).